Submission Details
| 510(k) Number | K042807 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 12, 2004 |
| Decision Date | February 08, 2005 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K042807 is an FDA 510(k) clearance for the ADVIA IMS VALPROIC ACID METHOD, a Enzyme Immunoassay, Valproic Acid (Class II — Special Controls, product code LEG), submitted by Bayer Healthcare, LLC (New York, US). The FDA issued a Cleared decision on February 8, 2005, 119 days after receiving the submission on October 12, 2004. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3645.
| 510(k) Number | K042807 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 12, 2004 |
| Decision Date | February 08, 2005 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LEG — Enzyme Immunoassay, Valproic Acid |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3645 |